Niken Indriyanti

Dr. Niken Indriyanti

Universitas Mulawarman
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Life
Verified
Journal Article
Open access
PDF file
Islamudin AhmadIslamudin Ahmad
Islamudin Ahmad
WPWisnu Cahyo Prabowo
Wisnu Cahyo Prabowo
MAMuhammad Arifuddin
Muhammad Arifuddin
JFJaka Fadraersada
Jaka Fadraersada
NINiken Indriyanti
Niken Indriyanti
SDSukanya Dej-adisai
Sukanya Dej-adisai
Mitragyna is a genus belonging to the Rubiaceae family and is a plant endemic to Asia and Africa. Traditionally, the plants of this genus were used by local people to treat some diseases from generation to generation. Mitragyna speciosa (Korth.) Havil. is a controversial plant from this genus, known under the trading name “kratom”, and contains more than 40 different types of alkaloids. Mitragynine and 7-hydroxymitragynine have agonist morphine-like effects on opioid receptors. Globally, Mitragyna plants have high economic value. However, regulations regarding the circulation and use of these commodities vary in several countries around the world. This review article aims to comprehensively examine Mitragyna plants (mainly M. speciosa) as potential pharmacological agents by looking at various aspects of the plants. A literature search was performed and information collected using electronic databases including Scopus, ScienceDirect, PubMed, directory open access journal (DOAJ), and Google Scholar in early 2020 to mid-2021. This narrative review highlights some aspects of this genus, including historical background and botanical origins, habitat, cultivation, its use in traditional medicine, phytochemistry, pharmacology and toxicity, abuse and addiction, legal issues, and the potential of Mitragyna species as pharmaceutical products.

26 November 2017 in Pharmacognosy Journal
Verified
Journal Article
Open access
PDF file
Islamudin AhmadIslamudin Ahmad
Islamudin Ahmad
NANeneng Siti Silfi Ambarwati
Neneng Siti Silfi Ambarwati
NINiken Indriyanti
Niken Indriyanti
YSYurika Sastyarina
Yurika Sastyarina
LRLaode Rijai
Laode Rijai
AMAbdul Mun’iM
Abdul Mun’iM
Background: Bulbs of Bawang Dayak (Eleutherine palmifolia L. Merr; Synonym: Eleutherine americana L. Merr) from family Iridaceae is widely found and grown in Kalimantan island. The local tribe "Dayak" commonly consume this plant and become a traded commodity in traditional markets. This plant is trusted to treat various diseases. Objective: The present study aims to determine the effect of blood glucose reduction from bulbs of Bawang Dayak based on the use of different extraction methods using oral glucose tolerance test. Method: Dried sample was extracted with methanol using maceration, reflux, and Soxhlet method, respectively. The measurement of blood glucose reduction was performed using oral glucose tolerance test in vivo method and was analyzed using statistical comparison (Two-Way-ANOVA). Results: Based on the each extraction results was obtained yields of as 8.636% (reflux method), 11.87% (maceration method), and 14.023% (soxhlet method). While the results of blood glucose lowering effect on each extract were used, there were significant differences in statistical tests and organ index. Conclusion: This result is a preliminary stage and the information is invaluable for further research.

10 May 2018 in Pharmacognosy Journal
Verified
Journal Article
Open access
PDF file
NINiken Indriyanti
Niken Indriyanti
AGAfrillia Nuryanti Garmana
Afrillia Nuryanti Garmana
FSFinna Setiawan
Finna Setiawan

1 November 2017 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Closed access
NINiken Indriyanti
Niken Indriyanti
JSJoewono Soeroso
Joewono Soeroso
JKJunaidi Khotib
Junaidi Khotib
Ethyl acetate fraction of Kalanchoe pinnata (Lmk) Pers leaves (EF-KP) is a potential material to be developed for lupus treatment. The aim of this research was to measure the effects of the EF-KP on lupus arthritis mice. The research was performed by testing of CD123+IFN-α+ dendritic cells and CD68+IL-6+ macrophages as the main biomarkers by using flow cytometry methods, and then the outcomes were directly observed in the joint’s tissue structure. The results of the research were analyzed by using statistics. The EF-KP reduces the relative percentages of CD123+IFN-α+ dendritic cells significantly (p0.05). Finally, the outcome to the grade of joint damage was scored by using Pritzker method. The treated groups have one grade lower, and the joint spaces were narrower than the untreated group. The results show the ability of the active compounds in EF-KP, which are comparable to 0.042 mg/Kg quercetin, to inhibit the progress of lupus arthritis pathogenesis in mice. It reveals the effectiveness of the EF-KP in human with lupus arthritis. However, the further clinical research is necessary.

31 December 2011 in Journal Of Tropical Pharmacy And Chemistry
Verified
Journal Article
Closed access
NINiken Indriyanti
Niken Indriyanti
AGAfrillia Nuryanti Garmana
Afrillia Nuryanti Garmana
Cocor bebek Plants (Kalanchoe pinnata) has been observed to have a potent immunosuppressant compounds in BALB/c mice with Delayed Type Hypersensitivity test (DTH). Compounds are efficacious immunosuppression can be used for treatment of autoimmune diseases such as lupus. The purpose of this study was knowing the class of compounds in leaf extracts cocor bebek and test whether the extract can prevent the occurrence of lupus in test animals. Methods: In this study the identification of classes of compounds present in Cocor bebek leaf extracts and testing imunnosupression activities from test animals BALB/c mice induced lupus using 2,6,10,14 tetramethylpentadecane (TMPD). Parameters measured lupus glomerulonephritis which was known by the presence of proteinuria using a test strip supported by data on changes in weight. Results: Extracts of cocor bebek leaves positive contain tannins, flavonoids, saponins and steroid / triterpene. Mice given the extract of Cocor bebek leaves every day until the 3rd month after not having induced proteinuria, while untreated mice had proteinuria up to +2 (proteinuria levels> 30 mg / dL). Key words : Cocor bebek, BALB/c mice, lupus, TMPD, glomerulonefritis ABSTRAK Tanaman cocor bebek (Kalanchoe pinnata) telah diteliti memiliki senyawa yang berkhasiat immunosupresan pada mencit BALB/c dengan uji Delayed Type Hypersensitivity (DTH). Senyawa yang berkhasiat imunosupresan dapat digunakan untuk penanganan penyakit autoimun, misalnya lupus. Tujuan penelitian ini adalah Mengetahui golongan senyawa dalam ekstrak daun cocor bebek dan menguji apakah ekstrak tersebut dapat mencegah terjadinya lupus pada hewan uji. Metode : Pada penelitian ini dilakukan identifikasi golongan senyawa yang ada dalam ekstrak daun cocor bebek dan pengujian aktivitas imunosupresannya terhadap hewan uji mencit BALB/c yang diinduksi lupus menggunakan 2,6,10,14 tetramethylpentadecane (TMPD). Parameter lupus yang diukur adalah glomerulonefritis yang diketahui dengan adanya proteinuria menggunakan strip test didukung dengan data perubahan berat badan. Hasil : Ekstrak daun cocor bebek positif mengandung tanin, flavonoid, saponin dan steroid/triterpen. Mencit yang diberi ekstrak daun cocor bebek setiap hari sampai bulan ke-3 setelah diinduksi tidak mengalami proteinuria, sedangkan mencit yang tidak ditreatmen mengalami proteinuria sampai +2 (kadar proteinuria >30 mg/dL). Kata kunci : cocor bebek, mencit BALB/c, lupus, TMPD, glomerulonefritis.

10 April 2018 in Journal of Young Pharmacists
Verified
Journal Article
Open access
NINiken Indriyanti
Niken Indriyanti
JSJoewono Soeroso
Joewono Soeroso
JKJunaidi Khotib
Junaidi Khotib
Background: Quercetin-3-O-rhamnoside (QUE) has anti-inflammatory and anti-oxidative effects which probably beneficially used in lupus. Objective: This research was focused on analyzing the effects of QUE on FOXP3 modulation to result in an anti-inflammatory outcome in the kidney of severe lupus mice. Methods: This research used Pristane-induced female BALB/c lupus mice, and the biomarkers involved in were CD4+CD25+ T reg cells, FOXP3 T cells, anti-Sm, IL-6, and histopathology assessment of the kidney of lupus mice. The QUE group was treated and compared to the negative control which received placebo, and the positive control which received cyclophosphamide. Results: QUE increased the number of CD4+CD25+ T reg cells (negative control: 3.01±3.43%; QUE: 18.77±5.12%; positive control: 3.26±11.09%), and FOXP3 significantly (p <0.05) (negative control: 1.14±0.54%; QUE: 2.00±1.45%; positive control: 1.73±1.14%). The anti- Sm level did not decrease, meanwhile the IL-6 decreased significantly, and the histopathological assessment of the kidney reveal the repairing effects of QUE on glomeruli. Conclusion: QUE has an anti-inflammatory activity which reduces the severity of lupus nephritis signs in lupus mice by initially increasing the CD4+CD25+ and FOXP3+ Tregs numbers. QUE is potential to be further developed as a safe treatment choice for lupus nephritis. Key words: Glomerulonephritis, IL-6, Lupus, Pristane, T regs.